New mask can kill SARS virus: Mitsubishi Heavy

New mask can kill SARS virus: Mitsubishi Heavy

TOKYO, Japan - A model wears a mask that Mitsubishi Heavy Industries Ltd. claims can kill the SARS virus through a special enzyme-woven fabric. The company said Jan. 9 it will put the mask on sale by the end of this month. (Kyodo)

  • Product Code
  • ILEA000022832
  • Registered date
  • 2004/1/09 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1228 × 1338 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 153.16(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Toyota Industries factory searched over engine data fabrication case

    HEKINAN, Japan, Jan. 30 Kyodo - Transport ministry officials enter a Toyota Industries Corp. factory in Hekinan in Aichi Prefecture, central Japan, on Jan. 30, 2024, a day after the company admitted to having manipulated engine torque data for 10 vehicle models that are sold with its engines globally. (Kyodo)

      Sompo CEO to step down over Bigmotor insurance fraud scandal

      TOKYO, Japan, Jan. 26 Kyodo - Major Japanese insurance firm Sompo Holdings Inc. CEO Kengo Sakurada holds a press conference in Tokyo on Jan. 26, 2024, to announce he will step down at the end of March to take responsibility for the company's involvement in used car dealer Bigmotor Co.'s insurance fraud scandal. (Kyodo)

        Maglev train tunnel

        FUJIKAWA, Japan, Oct. 13 Kyodo - A ceremony is held in Fujikawa, Yamanashi Prefecture, on Oct. 13, 2023, to mark the completion of a 710-meter tunnel for Central Japan Railway Co.'s Linear Chuo Shinkansen maglev trains that will run between Nagoya and Tokyo at speeds of 500 kilometers per hour. (Kyodo)
          M'bishi Heavy gives up 1st Japan-made passenger jet project

          M'bishi Heavy gives up 1st Japan-made passenger jet project

          Mitsubishi Heavy Industries Ltd. CEO Seiji Izumisawa holds a press conference in Tokyo on Feb. 7, 2023, over the company's decision to terminate its plan to develop SpaceJet, Japan's first domestically manufactured passenger jet.
            M'bishi Heavy gives up 1st Japan-made passenger jet project

            M'bishi Heavy gives up 1st Japan-made passenger jet project

            Mitsubishi Heavy Industries Ltd. CEO Seiji Izumisawa holds a press conference in Tokyo on Feb. 7, 2023, over the company's decision to terminate its plan to develop SpaceJet, Japan's first domestically manufactured passenger jet.
              M'bishi Heavy gives up 1st Japan-made passenger jet project

              M'bishi Heavy gives up 1st Japan-made passenger jet project

              File photo taken in March 2020 shows Mitsubishi Heavy Industries Ltd.'s SpaceJet test plane at Nagoya airport in Aichi Prefecture, central Japan. The company announced the termination of its plan to develop Japan's first domestically manufactured passenger jet on Feb. 7, 2023.
                M'bishi Heavy gives up 1st Japan-made passenger jet project

                M'bishi Heavy gives up 1st Japan-made passenger jet project

                File photo taken in March 2020 shows Mitsubishi Heavy Industries Ltd.'s SpaceJet test plane at Nagoya airport in Aichi Prefecture, central Japan. The company announced the termination of its plan to develop Japan's first domestically manufactured passenger jet on Feb. 7, 2023.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      Mitsubishi Heavy Industries' new plant

                      Mitsubishi Heavy Industries' new plant

                      Photo taken Nov. 4, 2020, shows a new factory of Mitsubishi Heavy Industries Ltd. to manufacture engine parts for passenger aircraft in Nagasaki, southwestern Japan.